Sera from different age cohorts in Belgium show limited cross-neutralization between the mumps vaccine and outbreak strains

Abstract

A possible contribution of antigenic differences between the genotype A and G mumps virus as well as other immune factors, in addition to lower-than-optimal vaccination coverage and waning immunity, could explain the poor in vitro cross-neutralization and should be further studied.